Author
Listed:
- Mei-Ling Yang
(Yale University)
- Sheryl Horstman
(Benaroya Research Institute at Virginia Mason)
- Renelle Gee
(Yale University)
- Perrin Guyer
(Benaroya Research Institute at Virginia Mason)
- TuKiet T. Lam
(Yale University
Keck MS & Proteomics Resource, WM Keck Foundation Biotechnology Resource Laboratory)
- Jean Kanyo
(Keck MS & Proteomics Resource, WM Keck Foundation Biotechnology Resource Laboratory)
- Ana L. Perdigoto
(Yale University)
- Cate Speake
(Benaroya Research Institute at Virginia Mason)
- Carla J. Greenbaum
(Benaroya Research Institute at Virginia Mason)
- Aïsha Callebaut
(KU Leuven)
- Lut Overbergh
(KU Leuven)
- Richard G. Kibbey
(Yale University
Yale University)
- Kevan C. Herold
(Yale University
Yale University)
- Eddie A. James
(Benaroya Research Institute at Virginia Mason)
- Mark J. Mamula
(Yale University)
Abstract
Inflammation, including reactive oxygen species and inflammatory cytokines in tissues amplify various post-translational modifications of self-proteins. A number of post-translational modifications have been identified as autoimmune biomarkers in the initiation and progression of Type 1 diabetes. Here we show the citrullination of pancreatic glucokinase as a result of inflammation, triggering autoimmunity and affecting glucokinase biological functions. Glucokinase is expressed in hepatocytes to regulate glycogen synthesis, and in pancreatic beta cells as a glucose sensor to initiate glycolysis and insulin signaling. We identify autoantibodies and autoreactive CD4+ T cells to glucokinase epitopes in the circulation of Type 1 diabetes patients and NOD mice. Finally, citrullination alters glucokinase biologic activity and suppresses glucose-stimulated insulin secretion. Our study define glucokinase as a Type 1 diabetes biomarker, providing new insights of how inflammation drives post-translational modifications to create both neoautoantigens and affect beta cell metabolism.
Suggested Citation
Mei-Ling Yang & Sheryl Horstman & Renelle Gee & Perrin Guyer & TuKiet T. Lam & Jean Kanyo & Ana L. Perdigoto & Cate Speake & Carla J. Greenbaum & Aïsha Callebaut & Lut Overbergh & Richard G. Kibbey & , 2022.
"Citrullination of glucokinase is linked to autoimmune diabetes,"
Nature Communications, Nature, vol. 13(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-29512-0
DOI: 10.1038/s41467-022-29512-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-29512-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.